Q: Please u take on latest results & going forward.Appreciate u usual great services & views
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Can you please comment on $ISRG. I am planning in initiating a small position. Any info would be greatly appreciated.
Thanks Valter
Thanks Valter
Q: Hi 5i team. After being badly "burned" by healthcare companies over the last couple years (phm, vrx, cxr) I had sworn off investing in healthcare/ drug companies as every one I was invested in seemed to turn out to be giant scams. But, that being said, I find myself liking the idea of the technology behind RHT and I am considering investing in this recent pullback. On the flip side I used to feel the same about patient home monitoring (and we all know how that turned out). I guess I am looking for reassurance that RHT is a MUCH different home monitoring company than phm was, with competent management that aren't scamsters like Dalsin was, and describe the level of potential RHT has for future growth. I like the "tech" and "AI" component of this technology the best as I believe these will continue to be the highest sector of world growth going forward.
Also, in regards to the upcoming quarter; is there a negative setiment out there in regards to the release that you are aware of? Would a person be better off to buy the dip now, or wait until after the release? Thanks
Also, in regards to the upcoming quarter; is there a negative setiment out there in regards to the release that you are aware of? Would a person be better off to buy the dip now, or wait until after the release? Thanks
Q: We have a 3.5% weighting in JNJ. We like it for its exposure to the USD, its steady dividend income, its blue-chip size and very modest share price growth. However I am concerned about the potential losses arising from their "baby-powder" lawsuit. We have owned the stock for years. I am thinking about switching out around 2% weighting into PFE. Its dividend appears to be higher and its chart seems to be better.
Reading over 5i responses on JNJ you seem fairly sanguine about JNJ so I hesitate to sell. We are retired but not currently spending our USD dividends - they are kept for foreign travel.
I must say I like XBI's chart. However its dividend is much lower so potentially we would need to sell stock if we needed USD. XBI should lower our risk profile as it is an ETF which is probably a smart move.
My questions are...
1) Would you recommend selling all our part of our JNJ or just do nothing?
2) Would you recommend purchasing PFE or XBI or both?
Please deduct as many credits as you feel my question(s) justify.
Thank you for your assistance.
Jim
Reading over 5i responses on JNJ you seem fairly sanguine about JNJ so I hesitate to sell. We are retired but not currently spending our USD dividends - they are kept for foreign travel.
I must say I like XBI's chart. However its dividend is much lower so potentially we would need to sell stock if we needed USD. XBI should lower our risk profile as it is an ETF which is probably a smart move.
My questions are...
1) Would you recommend selling all our part of our JNJ or just do nothing?
2) Would you recommend purchasing PFE or XBI or both?
Please deduct as many credits as you feel my question(s) justify.
Thank you for your assistance.
Jim
Q: Regretting not purchasing IMV before the recent listing changes and stock run up that followed. Where are they at with trials and product testing? Is the current strength based on assumed approvals or have there been results driven reasons for the rise? Would 5i suggest waiting on this one or is it a speculative buy today?
Q: What do you think about Hamilton Thorne after their latest earnings report?
Best,
Linda
Best,
Linda
Q: This company has just had a 1 : 9.5 reverse stock split and is now listed on the Nasdaq. Do you feel that this has any impact on the companies/share price? Thanks, Leah
Q: Any reason for the 11% drop on Reliq today? Would you add to a position or wait after earnings? Thanks!
-
Johnson & Johnson (JNJ $179.29)
-
Pfizer Inc. (PFE $25.88)
-
Procter & Gamble Company (The) (PG $158.67)
Q: Hello 5i: Reading your answer today about JNJ and while you like it would maybe pick something else at this time, What would be your suggestions in the US,
Thank you as always. Barbara
Thank you as always. Barbara
Q: JNJ is looking very soft on the charts - understand they have some legal issues (which I don't understand ) I have a near full position - time horizon 2 years, hold or sell?? Thanks Jim.
Q: leaving out reljq, photon and box which i own lots of what is your single favorite small cap from now until year end.i know you do not like a timeframe but the risk is on me. dave
Q: In my TFSA I am thinking about swapping VMD for some additional shares in GUD. Do you think this switch makes sense as I try to keep my TFSA growing?
Thanks for your great service.
Bob.
Thanks for your great service.
Bob.
Q: Guys I know you are not especially U.S. - focused but what do you have to say about gene editing and the companies involved including CRSP, EDIT and NTLA.
Thank you
Kim
Thank you
Kim
Q: Hello 5i, what is your opinion on theses three companies for a 2-3 year hold? Would you invest in any of those? If not, do you have a better suggestion in the small cap area? Does not have to be in pharma/life science. Thanks for the great service!
Q: Given the recent news implying double the current revenues over the next three years what is your estimate of earnings for these years, and what would be your assumptions with respect to this development
Q: What is your outlook and recommendation on CRH. Thank you
Q: I have a small position in PFE (about 1%), and I am interested in increasing my position to about 2%-2.5% by selling off a similarly-sized position in BAC. My portfolio has about a 10% weighting in financials, while I only have about 4% in health care, which is why I wanted to make the shift. My question is whether I am better off simply topping up my PFE position, or selling PFE as well as BAC, and using the proceeds to buy either JNJ, MRK or GSK. I prefer to stay with larger cap names, and in this particular case, I am looking at US names exclusively. If you have another larger cap US name that may be worth considering, I would be very open to suggestions.
As an aside, I also have a 3% position in GUD which I plan to keep for the longer term.
Thanks so much for your time, and I look forward to your response.
As an aside, I also have a 3% position in GUD which I plan to keep for the longer term.
Thanks so much for your time, and I look forward to your response.
-
Atlantic Gold Corporation (AGB $2.92)
-
Knight Therapeutics Inc. (GUD $6.45)
-
Reliq Health Technologies Inc. (RHT)
Q: I have Gud in my TFSA, I want to sell GUD and buy Rht or Agb? And do you prefer rht over agb? Are they good entry level ? Your thought please, thanks always.
Q: Would you recommend RHT at this level? Thanks
Q: After announcement of $100m contracts on May 7,COV jumped from $3.67 to $7.50 before declining to $6.15 today.Please give a estimated value.Is this a good entry point?Txs for u usual great services & opinions. Looking forward to seeing Ryan on Market Call on May 24